Worth reading
42Recurring
Scored from 3 of 4 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
11
Number of director candidatesWording
Definitive
How definitive the wording is.Resolutions for the General Meeting of Shareholders
Annual (57th)2026
Jul 30
Date and time(start time: Not disclosed)35 days from this disclosure to the meeting
Matters for resolution1 item
Election of director candidates
Shareholder Proposal
None (not specified)
A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.Director nominee
11Nominees
1New
6Outside
| Item | Details |
|---|---|
| Type of shareholders' meeting | Annual (57th) |
| Date and time | Scheduled for 30 July 2026 (start time: Not disclosed) |
| Matters for resolution | Election of director candidates |
| Shareholder Proposal | None (not specified) |
| Director nominee | 11, including 1 new and 6 outside directors |
Items this document does not state (1)
Percentage voting in favor
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Tawaragi Tomiko (俵木登美子) has a career in pharmaceutical and medical device administration, among other areas, as set out in her professional history. Oishi Miya (大石美也) will retire because her term expires upon the conclusion of this general meeting of shareholders.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.